SLC5A1 and myocardial ischemia: A recent study showed that knock down of SGLT1 increased cell viability following hypoxia–reoxygenation, and protected against acute myocardial ischemia–reperfusion injury in both in vivo and ex vivo settings, without affecting glucose uptake [55].